CEO sold ~$236K of Gilead Sciences
Scheduled in advanceLoading…
Transaction May 10, 2024 · Disclosed Aug 5, 2026
Held by the filer's joint per the disclosure. Disclosed 817 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$1,001 - $15,000
Official band as filed. No midpoint or exact amount is implied
Joint
817 days
Days between the transaction date and the filing date
2 disclosures on this company by this filer
No other filers within 90 days
CEO sold ~$236K of Gilead Sciences
Scheduled in advanceCEO sold ~$1.19M of Gilead Sciences
Scheduled in advanceCEO sold ~$808K of Gilead Sciences
Scheduled in advance